A study of axitinib, a VEGF receptor tyrosine kinase inhibitor, in children and adolescents with recurrent or refractory solid tumors: A Children’s Oncology Group phase 1 and pilot consortium trial (ADVL1315)
- James I. Geller
- , Elizabeth Fox
- , Brian K. Turpin
- , Stuart L. Goldstein
- , Xiaowei Liu
- , Charles G. Minard
- , Rachel A. Kudgus
- , Joel M. Reid
- , Stacey L. Berg
- , Brenda J. Weigel
Research output: Contribution to journal › Article › peer-review
51
Link opens in a new tab
Scopus
citations